Standard Biotools Inc. (lab 2.75 02/01/34)
13F holders, Q3 2024 (September 30)2holders −2
0new positions
2sold out
$0.99avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Standard Biotools Inc. (lab 2.75 02/01/34) in their 13F filings, down 2 from Q2 2024. 0 opened new positions and 2 sold out. The largest holders were Envestnet Asset Management Inc. ($20K) and Mariner, LLC ($10K).
- Company
- Standard Biotools Inc. (lab 2.75 02/01/34)
- CUSIP
- 34385PAA6
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $38K |
All 13F filers, Q2 2024 → Q3 2024: 38,000 shares sold, net −38,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Envestnet Asset Management Inc. | 0.00% | No change | 20,000 | $20K |
| Mariner, LLC | 0.00% | No change | 10,000 | $10K |
"% of holder's portfolio" is STANDARD BIOTOOLS INC (LAB 2.75 02/01/34)'s weight in each manager's 13F, not the share of Standard Biotools Inc. (lab 2.75 02/01/34) the manager owns.